New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

GNOMvsWDNAETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of
BioTech & Genomics
-0.12%
Full GNOM fund page
VS
ETF 2
WDNA

WisdomTree BioRevolution Fund

This fund is part of
BioTech & Genomics
-0.12%
Full WDNA fund page

Global X Genomics & Biotechnology ETF - USD (GNOM) and WisdomTree BioRevolution Fund (WDNA) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.45% for WDNA. GNOM is down -0.99% year-to-date (YTD) with -$2M in YTD flows. WDNA performs better with 4.96% YTD performance, and -$357K in YTD flows. Run a side-by-side ETF comparison of GNOM and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs WDNA performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

-400,000-300,000-200,000-100,0000Feb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
WDNA
-2.35%-0.46%
-3.29%+4.60%
-0.99%+4.96%
+29.80%+38.09%
-6.02%+12.49%
-51.80%n/a
Flows
GNOM
WDNA
--$357K
-$4M-$357K
-$2M-$357K
-$19M-$357K
-$115M-$524K
+$11M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
WDNA
+23.45%+22.81%
+30.08%+28.57%
+28.53%+24.57%
+33.47%n/a
Max drawdown
GNOM
WDNA
-10.89%-8.60%
-22.14%-17.47%
-46.50%-37.80%
-72.17%n/a
Max drawdown duration
GNOM
WDNA
48d48d
113d106d
1031d901d
1714dn/a
Trading data

Create an account to view trading data

Join for free
GNOM
WDNA
Last sale
3/11/2026 at 1:30 PM
$45.00
$17.67
Previous close
03/11/2026
$45.33
$17.74
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
GNOM
WDNA
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
GNOM
WDNA
Last price
$45.00
$17.67
1D performance
-0.74%
-0.39%
AuM$49.36 M$2.31 M
E/R0.5%0.45%
Characteristics
GNOM
WDNA
Management strategyPassivePassive
ProviderGlobal XWisdomTree
BenchmarkSolactive Genomics IndexWisdomTree BioRevolution Index
N° of holdings4675
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019June 3, 2021
ESGNoNo
Advertisement
Exposure

Countries

GNOM
USA
87.04%
Other
12.96%
WDNA
USA
82.35%
Other
17.65%

Sectors

GNOM
Health Care
87.95%
Other
12.05%
WDNA
Health Care
78.82%
Other
21.18%
Advertisement

Diversification

GNOM

Total weight of top 15 holdings out of 15

63.95%
WDNA

Total weight of top 15 holdings out of 15

37.91%

Top 15 holdings

Data as of January 31, 2026
GNOM
MODERNA INC
6.79%
ARROWHEAD PHARMACEUTICALS INC
6.14%
US74006W2070
5.75%
ILLUMINA
5.64%
GUARDANT HEALTH INC
5.47%
NATERA
4.30%
VERTEX PHARMACEUTICALS
4.08%
BIONTECH SE ADR
4.04%
BIOMARIN PHARMACEUTICAL
3.93%
AVIDITY BIOSCIENCES
3.73%
BIO-TECHNE CORP
3.69%
CRISPR THERAPEUTICS
3.05%
ALNYLAM PHARMACEUTICALS
2.58%
VERACYTE INC/D
2.50%
BRISTOL-MYERS SQUIBB
2.28%
WDNA
US86366E1064
3.83%
MODERNA INC
3.80%
NATERA
2.81%
LILLY
2.78%
JOHNSON&JOHNSON
2.75%
BIONTECH SE ADR
2.56%
DK0062498333
2.41%
PFIZER
2.34%
STOKE THERAPEUTICS INC
2.15%
AMGEN-T
2.15%
IONIS PHARMACEUTICALS INC
2.12%
BEAM THERAPEUTICS
2.08%
UTD THERAPEUT
2.08%
AMICUS THERAPEUTICS
2.05%
US0463531089
2.03%
Frequently asked questions about GNOM and WDNA

How have the GNOM and WDNA ETFs performed in 2026?

As of March 11, 2026, GNOM is down -0.99% year-to-date (YTD), while WDNA has returned 4.96%. That puts WDNA better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or WDNA?

Year-to-date, the GNOM ETF saw -$2M in flows, compared to -$357K for WDNA.

Which ETF is more volatile: GNOM or WDNA?

Over the past year, GNOM had a volatility of 30.08%, while WDNA experienced 28.57%.

Which ETF is bigger: GNOM or WDNA?

As of March 11, 2026, GNOM holds $49.36 M in assets under management (AUM), while WDNA manages $2.31 M.

What sectors do the GNOM and WDNA ETFs invest in?

GNOM leans toward sectors like Health Care. Meanwhile, WDNA focuses on Health Care.

What are the top holdings of the GNOM ETF and WDNA ETF?

GNOM top holdings include MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. WDNA holds in its top three: US86366E1064, MODERNA INC and NATERA.

Which ETF is more diversified: GNOM or WDNA?

GNOM holds 48 securities with 63.95% of its assets in the top 15. WDNA has 85 securities and a top 15 weight of 37.91%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast